Pseudomonas aeruginosa, as an opportunistic pathogen, establishes a chronic infection in the respiratory track of patients suffering from pneumonia and bronchiectasis, including cystic fibrosis. Biofilm formation inside the oversecreted mucus layer lining the patient airway and production of virulence factors, a process controlled by quorum sensing, are considered to be the major virulence determinants in P. aeruginosa pathogenesis. Recently, an abnormally thickened mucus layer was proven to be anaerobic. Given the fact that currently used antibiotics are less effective under anaerobic environments, these new findings lead us to change the way we confront P. aeruginosa infection. This article reviews pathological features of patient airways that become susceptible to P. aeruginosa infection and bacterial adaptation that contributes to the prolonged survival inside the patient airway.
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Bacterial virulence factors are (i) molecules produced by microbial pathogens that induce specific disease symptoms in the host and (ii) mechanisms by which pathogens deliver (or secrete) those molecules. But, in broad terms, virulence factors include any factors that contribute to the successful colonization of host tissues. As an extracellular pathogen, P. aeruginosa secretes an array of virulence factors, whose production is controlled by quorum sensing, a cell-density dependent gene regulatory pathway. Effectors to be secreted include elastase (17, 18) , alkaline protease (19, 20) , exotoxins (21, 22) , phospholipase (23, 24) , and pyocyanin (25) . These molecules exert toxic effects on human hosts by directly degrading host tissues or eliciting oxidative stress.
II. Abnormal mucus environments in airway diseases
Under normal airway environments, invading microorganisms are usually expelled and/or cleared by the upper airway innate immune defense system that includes the mucociliary clearance (26~28). P. aeruginosa being an opportunistic pathogen, however, can cause persistent infection in patients with abnormal airway mucus secretion.
Patients suffering from cystic fibrosis (CF) (1, 29) , bronchiectasis (30, 31) , and pneumonia (32) are especially vulnerable to P. aeruginosa infection. Among many pathological symptoms, aforementioned airway diseases are characterized with the noticeable oversecretion of mucus on top of the airway epithelium that debilitates the mucociliary clearance activity (1, 33) . As depicted in Figure 1 , mucus hypersecretion is often accompanied with the depletion of the periciliary liquid layer (PLL) and subsequent loss of mucociliary clearance activity.
CF is a genetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene coding for Cl -transport channel across the apical surface of secretory cells (34) . In CF, hyperactivation of epithelial Na + channel (ENaC), an event that occurs due to the mutation in the CFTR gene (35) , drives the isotonic absorption of H 2 O and ions into the airway epithelium resulting in the dehydration of PLL and thus the formation of a stagnant mucus layer (1) . Bronchiectasis (BE) is a disease state where the bronchial tree is irreversibly dilated.
BE is caused by early childhood bacterial infections or pulmonary tuberculosis and patients with BE are highly susceptible to secondary infection by microbial pathogens including P. aeruginosa. BE is also featured with mucus hypersecretion and impaired mucociliary clearance activity (33) . A recent report demonstrated that neutrophil protease present in large quantity in sputum samples from the BE patients stimulates the secretory response in tracheal submucosal glands (33) .
Much evidence indicated that the oversecreted and stationary mucus layer provides a nice "habitat" for P.
aeruginosa to colonize and proliferate (1, 36) . Importantly, this abnormally altered mucus layer (Fig. 1B ) also renders the host immune system ineffective against P. aeruginosa Maintenance of periciliary liquid layer (PLL) with constant depth and appropriate movement of the mucus layer on top of the PLL, which mediates the mucociliary clearance, is achieved in normal airways. In diseased states, however, PLL is depleted and an abnormally oversecreted (and thus, highly viscous) mucus layer is formed. This mucus layer is highly susceptible to bacterial colonization. Recently, the stagnant mucus layer lining the airway of chronic CF patients was reported to be anaerobic (3, 36) .
The lack of oxygen potential is ascribed to (i) the limited oxygen transport into the mucus layer due to its increased viscosity and (ii) a high rate of oxygen consumption by immune-related and airway epithelial cells. This new observation provides a new insight into the establishment of P. aeruginosa infection under anaerobic condition.
III. Anaerobic growth of P. aeruginosa
Being an obligate respirer, P. aeruginosa is also capable of generating energy even in the absence of oxygen using As shown in Figure 2B , pH gradient across the inner membrane can still be generated when NO 3 - (43, 44) . This result suggests that P.
aeruginosa proliferates well inside the anaerobic mucus layer exploiting the compounds produced by the host and may provide an insight into why P. aeruginosa has been such a competitive colonizer in the patient airways.
IV. P. aeruginosa biofilm and a new emerged concept on the enhanced biofilm formation during anaerobic respiration
Biofilm formation is often described as a process by which bacterial cells develop into a sessile community (45) .
Steps that can be clearly distinguished during this process There are three well-characterized QS systems in P.
aeruginosa: las, rhl, and pqs. The las and rhl systems were initially identified to be essential for elastase and rhamnolipid production, respectively (62, 63 
VI. Conclusions
Although patient airways are equally exposed to diverse bacterial pathogens, P. aeruginosa has been a major 
